GLP-1 agonists
4 stories
-
healthWeight Loss Surgery Outperforms GLP-1 Drugs for Heart Health
New analysis reveals metabolic and bariatric surgery offers superior cardiovascular protection compared to GLP-1 drugs for individuals with obesity and type 2 diabetes.
-
healthWeight-Loss Drugs: Crucial Dietary Data Overlooked in Trials
New review reveals GLP-1 agonist trials rarely assess impact on diet, despite widespread use for weight and glycemic control.
-
healthGLP-1 Drugs Show Promise in Reducing Dementia Risk for Kidney Disease Patients
New research indicates GLP-1 receptor agonists may significantly lower dementia and Alzheimer's risk in patients with chronic kidney disease and type 2 diabetes.
-
healthNew Study: GLP-1 Agonists Significantly Cut Endometrial Cancer Risk
Research reveals GLP-1 receptor agonists combined with progestins dramatically reduce endometrial cancer risk and the need for hysterectomies in women with benign uterine conditions.